Blog

On Earth Day, the Environmental Integrity Project (EIP), a CPR ally, released a new report on nitrogen pollution from poultry operations in the Chesapeake Bay watershed. Using data from the Chesapeake Bay Program’s pollution modeling program, EIP found that approximately 24 million pounds of nitrogen pollution from the poultry industry entered the Chesapeake Bay’s tidal waters in 2018. That's more than from urban and suburban stormwater runoff in Maryland and Virginia combined, and it can contaminate drinking water sources of nearby communities and feed huge algal blooms in the Bay that block sunlight, choking off fish and plant life.

On April 17, CPR Board President Rob Verchick joined EPA enforcement chief Susan Bodine and other panelists for an American Bar Association webinar on environmental protections and enforcement during the COVID-19 pandemic. During the event, Bodine expressed "surprise" that the agency's pandemic enforcement policy was so roundly criticized, but she shouldn't have been caught off guard by those critiques. As Verchick noted during the discussion, "The problem with [weakening monitoring and pollution reporting requirements] is that fenceline communities have no idea where to look. They have no idea if the facilities in their backyards are…taking a holiday from pollution requirements or not."

With COVID-19 cases contracted at work on the rise, labor and employment attorneys, businesses, advocates, and workers are all wondering if their state’s workers’ compensation law will apply, and alternatively, if an ill worker could file a lawsuit against their employer. The answers to these questions are not simple, as workers’ compensation laws vary by state, and when it comes to occupational diseases, the applicability of workers’ comp is often even more complicated. In a recent post on Workers’ Compensation Law Prof Blog, CPR Member Scholar Michael Duff discusses the so-called workers’ compensation “grand bargain,” under which workers receive no-fault benefits for work-related injuries and illnesses in exchange for giving up their right to file a lawsuit against their employer. In his post, Duff explores the circumstances in which a worker who has contracted COVID-19 at work may still have the right to file a lawsuit (getting around the “exclusivity bar”), as illustrated by a recently filed wrongful death case in Illinois, Evans v. Walmart. In this case, plaintiffs argue that two Walmart employees, Wando Evans and Phillip Thomas, passed away due to complications from COVID-19 contracted while working for the big box retailer.

As the coronavirus pandemic wears on, reports abound of essential frontline workers laboring without such basic protective gear as masks, gloves, soap, or water; with improper distancing between workstations and coworkers; and in workplaces alongside infected colleagues. So far, nearly 4,000 workers have filed complaints with the federal Occupational Safety and Health Administration (OSHA), raising concerns about health and safety conditions inside the workplace. Yet the agency has been largely absent at a time it is most needed. Shamefully, as COVID-19 illnesses rise in slaughterhouses, grocery stores, hospitals, and other worksites across the nation, the agency has chosen to go against its very mission of protecting America’s workers, ignoring calls to adopt emergency standards and rolling back its enforcement efforts.

During the coronavirus crisis, Dr. Anthony Fauci has become the voice of reason. Much of the public turns to him for critical information about public health while even President Trump finds it necessary to listen. In the Trump era, no one plays that role in the environmental arena. The result is a mindless campaign of deregulation that imperils public health and safety. We can't clone Dr. Fauci or duplicate the unique circumstances that have made his voice so powerful. However, we can do several things that would make it harder for administrations to ignore science.

On April 14, CPR's James Goodwin took part in a virtual hearing, hosted by the Union of Concerned Scientists, on the EPA's "censored science" rule, an effort by EPA to exclude from its rulemaking process a range of scientific studies that industry finds uncongenial to its anti-regulatory views. In his testimony, Goodwin dismantles EPA's contention that the rule is grounded in law, observing that there are no credible legal underpinnings for the proposal.

On April 29, the Center for Progressive Reform (CPR) will host a webinar to discuss the public health and policy implications of COVID-19 and to highlight the many policy parallels between the pandemic and climate change. Speakers include Daniel Farber, JD, of UC Berkeley (and a CPR Member Scholar); Monica Schoch-Spana, PhD, of the Johns Hopkins Bloomberg School of Public Health; and Aaron Bernstein, MD, MPH, of Boston Children’s Hospital and the Harvard Medical School. Join us!

Americans are experiencing a tidal wave of food insecurity related to the coronavirus pandemic. Historic unemployment claims and surging demand at food banks are laying bare the precarious circumstances of many of our citizens and the inadequacy of our social safety net. We can learn from the coronavirus epidemic--and we must in order to prevent human suffering in the future. Taking stock and then reforming our policies should start now while legislative momentum is possible--not after the country has moved past the apex of the disease. In a recent episode of the podcast, Good Law/Bad Law, Laurie Ristino joined host Aaron Freiwald to discuss the vital connection between the 2018 Farm Bill, the pandemic, and the startling food insecurity so many Americans are now facing.

Over the last month, the scripts of the daily White House COVID-19 briefings have followed a familiar pattern: President Trump leads off with assurances that the crisis remains “totally under control” and that miracle cures are just around the corner. Then agency experts come to the microphone and tell a very different story. For example, on March 19, the president reported that the Food and Drug Administration “very, very quickly” approved a malaria drug, hydroxychloroquine, for treating COVID-19 that it had previously approved for lupus, malaria, and rheumatoid arthritis. Later in the briefing, Dr. Anthony Fauci, the long-time head of the National Institute for Allergy and Infectious Diseases, cautioned listeners that controlled testing would have to be completed before we know whether the drug works on the novel coronavirus. And FDA later warned that it had definitely not approved hydroxychloroquine for fighting the virus.